Back

Rilonacept as monotherapy for long-term recurrent pericarditis management: sustained disease control over three years

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pericarditis Pericarditis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Dor Lotan

Columbia University Irving Medical Centre, New York (United States of America)

7 More presentations in this session

Presentation thumbnail
Rilonacept reduces pericarditis recurrence risk: clinical outcomes from the RESONANCE patient registry
Doctor P. Cremer (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Pushing boundaries, not the heart: a comparative look at pericarditis recurrence in athletes
Doctor E. Angelu (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Unveiling hidden myocardial dysfunction in acute pericarditis: the prognostic power of GLS
Doctor A. Andreis (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: a case series
Doctor F. Moda (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Recurrent pericarditis: is Anakinra the only solution? Diagnostic and therapeutical insights from long-term follow-up of a large monocentric cohort
Doctor A. Giordani (Padova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pericarditis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Multi-year recurrent pericarditis disease duration in Italian patients: clinical outcomes after cessation of long-term IL-1 pathway inhibition provide insights for chronic management
thumbnail
Congress Presentation
Rilonacept reduces pericarditis recurrence risk: clinical outcomes from the RESONANCE patient registry
thumbnail
Congress Presentation
Real-life experience with rilonacept for the treatment of recurrent pericarditis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources